澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - simvastatin, quantity: 10 mg - tablet, film coated - excipient ingredients: ascorbic acid; lactose monohydrate; butylated hydroxyanisole; citric acid monohydrate; pregelatinised maize starch; microcrystalline cellulose; magnesium stearate; titanium dioxide; hypromellose; purified talc; hyprolose; iron oxide yellow; iron oxide red; iron oxide black - simvastatin is indicated as an adjunct to diet for treatment of hypercholesterolaemia. prior to initiating therapy with simvastatin, secondary causes of hypercholesterolaemia (eg poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated. simvastatin is indicated in patients at high risk of chd (coronary heart disease) (with or without hypercholesterolaemia), including patients with diabetes, history of stroke or other cerebrovascular disease, peripheral vessel disease, or with existing chd to reduce the risk of cardiovascular death, major cardiovascular events including stroke, and hospitalisation due to angina pectoris. these effects do not replace the need to independently control known causes of cardiovascular mortality and morbidity such as hypertension, diabetes and smoking.

新加坡 - 英文 - HSA (Health Sciences Authority)

dnr wheels pte. ltd. - anaesthesiology - intended for individual use by patients with respiratory disorders who require supplemental oxygen. the device is not intended to sustain or support life. the concentrator is intended for use within a home or institutional environment.

新加坡 - 英文 - HSA (Health Sciences Authority)

dnr wheels pte. ltd. - anaesthesiology - intended to be used by patients with respiratory disorders who require supplemental oxygen. the device is not intended to sustain or support life. the concentrator is capable of operation by the patient in a home environment, in an institutional environment or in a vehicle or other mobile environment.

马耳他 - 英文 - Medicines Authority

kleva s.a. 189 parnithos avenue, 13671 acharnai, attiki, greece - simvastatin - film-coated tablet - simvastatin 10 mg - lipid modifying agents

以色列 - 英文 - Ministry of Health

unipharm ltd, israel - simvastatin - film coated tablets - simvastatin 10 mg - simvastatin - coronary heart disease : in patients with coronary heart disease and hypercholesterolemia simvacor is indicated to: reduce the risk of total mortality by reducing coronary death reduce the risk of non-fatal myocardial infarction reduce the risk for undergoing myocardial revascularization procedures. reduce the risk of stroke and transient ischemic attacks (tia). hyperlipidemia: simvacor is indicated as an adjunct to diet to reduce elevated total-c ldl-c apo b and tg and to increase hdl-c in patients with primary hypercholesterolemia( heterozygous familial and nonfamilial) and mixed dyslipidemia (frederickson types iia and iib) simvacor therefore lowers the ldl-c/hdl-c and the total-c/hdl-c ratios. homozygous familial hypercholesterolemia: simvacor is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol ldl-cholesterol and apolipoprotein b in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate. hypertri

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

invacare australia pty ltd - 12873 - stationary oxygen concentrator - the invacare platinum 5nxg concentrator is used by patients with respiratory disorders who require supplemental oxygen. the device is not intended to sustain or support life.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

invacare australia pty ltd - 34436 - device, oxygen therapy - allows patients to fill their own portable cylinders direct from the invacare oxygen concentrator with oxygen

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

invacare australia pty ltd - 47478 - alternating-pressure bed mattress overlay system - this pressure redistribution mattress and control unit are intended to be used in conjunction with an appropriately sized bed frame, as part of an overall pressure ulcer prevention program of care. it can be used safely in static mode (deflated) for static pressure redistribution, or in dynamic mode (inflated) should an alternating pressure support surface be required. any other use is prohibited. this product has been designed to deliver effective pressure reduction to users, when the product is in normal use which is defined by invacare ltd as when the support surface is covered with a cotton, cotton combination or linen bed sheet, and any one of these would be the only item deployed between the support surface and the user.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

invacare australia pty ltd - 11093 - cushion, - the invacare flo-tech solution cushion uses a combination of a slim, shaped foam cushion base and a dual layer of gel sacs over the ischial and sacral area. the dual gel sacs and the unique moulded foam shape of the solution increases the support surface area. this delivers a superior level of protection for those patients identified as being at very high risk of developing pressure ulcers, or for those with already established tissue damage.

马来西亚 - 英文 - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

y.s.p. industries (m) sdn bhd - simvastatin -